Drug
Alxn1007
Alxn1007: highest development phase Phase 1, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALXN1007 NCT01454986 | Phase 1 | Healthy |
Latest
No recent events.
Follow Alxn1007 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.